Increase the proportion of females who get screened for cervical cancer — C‑09 Data Methodology and Measurement

About the National Data


Baseline: 75.0 percent of females aged 21 to 65 years received a cervical cancer screening based on the most recent guidelines in 2019

Target: 79.2 percent

Number of females aged 21 to 65 years who received cervical cancer screening based on the most recent USPSTF recommendation and who have not had a hysterectomy.
Number of females aged 21 to 65 years who have not had a hysterectomy, excluding those with a history of cervical cancer.
Target-setting method

Percentage point improvement

Target-setting method details
Percentage point improvement from the baseline using Cohen's h effect size of 0.10.
Target-setting method justification
Trend data were evaluated for this objective but it was not possible to project a target because the slope of the line was not statistically significant, and the trend was moving away from the desired direction. A percentage point improvement was calculated using Cohen's h effect size of 0.1. This method was used because the Healthy People 2030 Workgroup Subject Matter Experts (SMEs) expected the overall percentage to continue to be difficult to change. Although this target is ambitious, the SMEs believed that progress may be made through multicomponent interventions, especially for medically underserved women.


Methodology notes

Data include women who have had a Pap test within the last 3 years. Women who answered "Had hysterectomy" to the third question or did not answer "No" to the fourth question are excluded from the sample. Healthy People 2020 uses the U.S. Preventive Services Task Force (USPSTF) guidelines to measure this objective and the current USPSTF guidelines recommend Pap test every 3 years for women aged 21 to 65 years. If a woman is age 30 to 65 years, USPSTF recommends either an HPV test alone or in combination with a Pap test every 5 years. The USPSTF also recommends against routine Pap smear screening for women who have had a total hysterectomy for benign disease.


Comparable HP2020 objective
Modified, which includes core objectives that are continuing from Healthy People 2020 but underwent a change in measurement.
Changes between HP2020 and HP2030
This objective differs from Healthy People 2020 objective C-15 in that the measure was revised to match updated screening recommendations put forth by the U.S. Preventative Services Task Force (USPSTF).
Revision History

In 2023, due to the 2019 NHIS survey redesign and a revised denominator to exclude women with a history of cervical cancer, the baseline was changed from 80.5% in 2018 to 75.0% in 2019 and the target was chnged from 84.3% to 79.2%.

1. Effect size h=0.1 was chosen to correspond with 10% improvement from a baseline of 50%.